Answers are grounded in this paper and cite their sources.
Demonstrates automated discrimination of exosome phenotypes in clinical serum samples, suggesting improved liquid biopsy techniques.
MXene emitter with a proximity-dependent "signal-off-on" aptamer strategy. Upon target recognition, the thermodynamically favored desorption of methylene blue-labeled aptamers triggers a dramatic ECL signal recovery, while the resulting multifeatured sensing data are processed using a support vector machine (SVM) algorithm. The sensing platform achieves a high quenching efficiency of 99.8% and a low limit of detection of 35 particles/μL for MCF-7 exosomes without requiring enzymatic amplification. Furthermore, integrating the SVM model with 3D principal component analysis enables the highly accurate and automated discrimination of varying exosome phenotypes derived from distinct cell lines in clinical serum samples, establishing a smart, AI-empowered paradigm for liquid biopsy.
No takes yet. Share an insight, caveat, or question.
Dots E2E (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: